Harish Shah
Hematology & Oncology · Wayne, NJNPI 1619952181
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,766 and has fallen 99.3% since, to $18 in 2024. That places this record below the midpoint for hematology & oncology clinicians in NJ, where the typical reported total is $2,686.
Across 129 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$375
- Johnson & Johnson$306
- E.r. Squibb & Sons, L.L.C.$268
- AstraZeneca$237
- Novartis$236
- AbbVie$166
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,96996%
- Education$1134%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 11 | $375 |
| Johnson & Johnson | 13 | $306 |
| E.r. Squibb & Sons, L.L.C. | 13 | $268 |
| AstraZeneca | 9 | $237 |
| Novartis | 11 | $236 |
| AbbVie | 4 | $166 |
| Eisai Inc. | 5 | $165 |
| Sanofi | 4 | $165 |
| Tesaro, Inc. | 3 | $151 |
| Boston Scientific | 1 | $150 |
| Bristol Myers Squibb | 11 | $148 |
| Gilead(2 entities) | 3 | $138 |
| Amgen | 8 | $116 |
| Pfizer | 6 | $82 |
| Merck | 6 | $80 |
| Bayer | 3 | $41 |
| Astellas Pharma US Inc | 3 | $40 |
| Daiichi Sankyo Inc. | 3 | $38 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $30 |
| Seagen Inc. | 2 | $27 |
| Lilly USA, LLC | 2 | $26 |
| Exelixis Inc. | 1 | $20 |
| Biocon Biologics Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,081 in reported general payments places this provider in the 50th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in Wayne
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Joshua StraussSpringfield$739K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
- Ashish ShahSpringfield$394K
- Carl HenningsonManasquan$349K
- Anthony BottiLivingston$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.